Articles

Podcasts

Videos

Clinical

A study published this week by the American Heart Association found myocarditis was more common after COVID-19 infection than after COVID-19 vaccination.

Risk of Myocarditis Higher After COVID-19 Infection Than After Vaccination

The Cambridge-MA., company accuses Pfizer and BioNTech of copying patented technology in the development of their COVID-19 vaccine.

Moderna Sues Pfizer-BioNTech Over mRNA Technology Infringement

Pfizer-BioNTech and Moderna have developed new booster shots optimized for Omicron. They could be approved as soon as Labor Day. 

FDA Plans to Approve Omicron-Targeting Booster Vaccines

If granted the Emergency Use Authorization (EUA), this vaccine would be available for individuals 18 years and older. 

Moderna Files for Authorization for Its Bivalent COVID-19 Vaccine Booster

Read this week’s top infectious disease stories you may have missed, including Dr. Anthony Fauci’s announcement.

Pfizer-BioNTech File for Authorization for Bivalent Booster COVID-19 Vaccine

A third dose of mRNA COVID-19 vaccines may allow most immune compromised patients with hematologic cancers to achieve antibody response levels similar to those of healthy adults after a two-dose series.

Third Dose of COVID-19 Vaccines May Boost Immunity in Patients with Hematologic Cancers

People who initially received an mRNA vaccine but were boosted with the Janssen vaccine had superior immune responses, the study found.

Report Finds "Mix-and-Match" COVID-19 Booster Approach More Effective

If it is granted an Emergency Use Authorization (EUA), the vaccine could be used as a booster dose for individuals 18 years and older vaccinated with any of the other available COVID-19 vaccines.  

Novavax Seeks FDA Authorization for its COVID-19 Vaccine as Booster

Investigators sought to address the effectiveness of vaccination after COVID-19  recovery.

COVID VACCINE RACE

Latest News